Riskpilot← Back to searchSign inGet full accessIN-LAB ApS
APSActiveCVR 12505280Kongevejen 155Diagnostic imaging services and medical laboratory activities · NACE 8691Est. 19886 employees
Revenue 2024
DKK 5,8M
+2% vs 2023
EBITDA margin
35.2%
+63% vs 2023
Equity ratio
73.8%
Financial strength
Net profit 2024
DKK 1,2M
+100% vs 2023
| Revenue | DKK 5,8M | +2% |
| EBITDA | DKK 2M | +63% |
| Net profit | DKK 1,2M | +100% |
| Total assets | DKK 6,6M | +3% |
| Equity | DKK 4,9M | +33% |
| Employees | 6 | — |
Legal name
IN-LAB ApS
CVR number
12505280
Legal form
Anpartsselskab
NACE code
8691 · Diagnostic imaging services and medical laboratory activities
Founded
7. september 1988
Share capital
DKK 125.000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to direktører i forening.
Company purpose
Selskabets formål er at drive Histo-Cytopatologisk Laboratorium.
Address
Kongevejen 155
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.027 | 1.463 | 1.642 | 2.103 | 2.670 | 3.161 | 2.375 | 2.420 | 10.683 | 11.767 | 12.009 | 5.650 | 5.781 |
| Staff expenses | -3.385 | -1.729 | -1.677 | -1.843 | -2.477 | -3.080 | -2.984 | -1.730 | -3.818 | -4.257 | -4.890 | -4.406 | -3.748 |
| EBITDA | 533 | -300 | -79 | 202 | 114 | -42 | -609 | 690 | 6.864 | 7.509 | 7.119 | 1.243 | 2.032 |
| Depreciation & amort. | -496 | -408 | -194 | -146 | -156 | -61 | -87 | -45 | -291 | -421 | -708 | -673 | -569 |
| EBIT | 37 | -708 | -273 | 56 | -42 | -102 | -696 | 645 | 6.573 | 7.088 | 6.410 | 570 | 1.463 |
| Net financials | 6 | -3 | 2 | 2 | -4 | 4 | -10 | -8 | -7 | -2 | 40 | 200 | 93 |
| Profit before tax | 43 | -711 | -271 | 58 | -46 | -98 | -707 | 637 | 6.565 | 7.086 | 6.450 | 770 | 1.556 |
| Tax | 11 | -176 | -61 | 26 | 7 | -21 | -155 | 140 | 1.444 | 1.544 | 1.407 | 160 | 335 |
| Net profit | 32 | -535 | -210 | 32 | -53 | -77 | -552 | 497 | 5.121 | 5.541 | 5.044 | 610 | 1.220 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.867 | 2.144 | 1.909 | 1.991 | 1.946 | 1.917 | 1.400 | 2.108 | 10.644 | 20.580 | 22.127 | 6.456 | 6.636 |
| Equity | 2.362 | 1.827 | 1.617 | 1.600 | 1.547 | 1.418 | 866 | 1.363 | 6.484 | 12.026 | 17.069 | 3.679 | 4.900 |
| Long-term debt | 62 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34 | 11 | 46 | 50 | 0 |
| Short-term debt | 443 | 316 | 292 | 391 | 399 | 499 | 534 | 745 | 4.125 | 8.456 | 4.924 | 2.677 | 1.686 |
| Total debt | 505 | 316 | 292 | 391 | 399 | 499 | 534 | 745 | 4.160 | 8.467 | 4.970 | 2.727 | 1.686 |
EBITDA margin
35.2%
This company
15.8%
Market median
+123% vs market
20122024
Equity ratio
73.8%
This company
38.2%
Market median
+93% vs market
20122024
Return on equity
24.9%
This company
18.4%
Market median
+35% vs market
20122024
Net profit margin
21.1%
This company
8.1%
Market median
+160% vs market
20122024
Asset turnover
0.87×
This company
1.12×
Market median
+22% vs market
20122024
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MS Management | Management | 2021 | — | — |
MG Management | Management | 2018 | — | — |
NI Management | Management | 2018 | — | — |
KL Management | Management | 2020 | — | — |
MI Founder | Founder | 1988 | — | — |
BL Founder | Founder | 1988 | — | — |
NG Audit | Audit | 1988 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ALERIS A/S | Company | 100.0% | 100.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ALERIS HOLDING DANMARK A/S
IN-LAB ApS Board members of IN-LAB ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mette Stokholm | Management | 0 companies |
| Michael Gram Kirkegaard | Management | 0 companies |
| Nis Isak Alstrup | Management | 0 companies |
| Kristina Lundtoft Nansen | Management | 0 companies |
| Marianne Illum | Founder | 0 companies |
| Birgit Larsen | Founder | 0 companies |
| Niels-Erik Gottlieb | Audit | 0 companies |